MediPal (MAHLY) Stock Price, News & Analysis

Company Overview

MediPal (OTCMKTS:MAHLY) is a healthcare investment holding company that offers a broad suite of products and services to hospitals, clinics and other medical institutions. The company’s core activities include the procurement, distribution and management of medical devices, consumable supplies and in-vitro diagnostics. MediPal’s integrated model spans the entire supply chain, from product sourcing and logistics to after-sales support and equipment maintenance.

In addition to its distribution business, MediPal provides specialized services such as clinical asset management and pharmacy operation solutions. The company works with a network of global medical-technology partners to bring surgical instruments, single-use urology products, respiratory devices, and point-of-care diagnostics to its customers. MediPal also offers workforce and staffing support, facilitating the placement of allied health professionals within its institutional client base.

Headquartered in Singapore, MediPal has established a presence across the Asia-Pacific region, serving markets in Malaysia, the Philippines, Indonesia and Australia. Over time, it has expanded its regional footprint through strategic partnerships and acquisitions, aiming to streamline healthcare logistics and enhance patient-care delivery. The company is overseen by a board of directors with experience in medical distribution, finance and international business development, although specific leadership details are not publicly disclosed in its OTC filings.

Key Stats

• Today's Range: $17.50 to $17.50
• 50-Day Range: $14.60 to $18.40
• 52-Week Range: $14.03 to $19.07
• Volume: N/A
• Average Volume: 1,149 shs
• Market Capitalization: N/A
• P/E Ratio: 0.18
• Dividend Yield: 130.32%
• Price Target: N/A
• Consensus Rating: N/A

MediPal Stock Analysis - MarketRank™

MediPal scored higher than 11% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for MediPal.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of MediPal is 0.18, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 280.92.

Price to Earnings Ratio vs. Sector

The P/E ratio of MediPal is 0.18, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 75.41.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

MediPal has a short interest ratio ("days to cover") of 6.

Change versus previous month

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

MediPal pays a meaningful dividend of 1.92%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

MediPal does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of MediPal is 23.88%. This payout ratio is at a healthy, sustainable level, below 75%.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

MediPal has a short interest ratio ("days to cover") of 6.

Change versus previous month

News and Social Media

• Score: 1.7 / 5
• News Sentiment: N/A

News Sentiment

MediPal has a news sentiment score of 0.98. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, MediPal insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 0.07% of the stock of MediPal is held by institutions.

MAHLY Stock Analysis - Frequently Asked Questions

How have MAHLY shares performed this year?

MediPal's stock was trading at $16.0750 at the beginning of the year. Since then, MAHLY shares have increased by 8.9% and is now trading at $17.50.

How do I buy shares of MediPal?

Shares of MAHLY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 9/13/2025
• Next Earnings (Estimated): 10/30/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Distribution
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:MAHLY
• CIK: N/A
• Web: www.medipal.co.jp
• Phone: 81-3-3517-5800
• Fax: N/A
• Employees: 12,795
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 0.18
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A